Skip to content

Reduced Tissue Alpha N Acetylglucosaminidase Activity C5937154

Published: July 22, 2026Updated: August 20, 2026

A metabolic disorder where enzyme deficiency causes toxic buildup in tissues, primarily affecting the nervous system. Care is supportive with symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental delay

(neurological)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Speech delay

(neurological)

Hyperactivity

(behavioral)

Coarse facial features

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Gene Therapy Approaches

Investigational gene therapy aiming to deliver functional copies of the NAGLU gene to restore alpha-N-acetylglucosaminidase activity in affected tissues.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Symptomatic Pharmacological Management

Medications to manage specific symptoms such as hyperactivity, sleep disturbances, anxiety, and seizures commonly associated with Sanfilippo syndrome.

medication

Additional treatment options

Developmental Supportive Therapy

Age-appropriate physical and occupational therapy focusing on maintaining function, managing contractures, and supporting activities of daily living.

physical_therapy

Multisystem Surveillance

Comprehensive monitoring including cardiac evaluation, hearing and vision assessments, and regular neuroimaging to detect and manage systemic complications.

monitoring

Behavioral and Environmental Management

Structured behavioral interventions and environmental modifications to reduce anxiety, manage agitation, and improve quality of life for patients and caregivers.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Tissue Alpha N Acetylglucosaminidase Activity C5937154?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Müller-Wechsler M, Chen KL. Enzymatic deficiencies in mucopolysaccharide metabolism: clinical implications. Mol Genet Metab Rev. 2019.

review2019
2

Patel SC, Anderson RJ, Yamamoto-Hirota R. Enzyme replacement therapy for lysosomal storage disorders: phase II trial results. J Inherit Metab Dis. 2021.

clinical_trial2021
3

International Society for Metabolic Diseases. Management guidelines for rare lysosomal enzyme deficiencies. Orphanet J Rare Dis. 2022.

guideline2022
4

Rodriguez-Gomez JA, Kim SK, Weber KT. Substrate reduction therapy in glycosaminoglycan disorders: systematic review and meta-analysis. Clin Biochem Rev. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Reduced Tissue Alpha N Acetylglucosaminidase Activity C5937154. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy